A detailed history of Advisor Net Financial, Inc transactions in Exact Sciences Corp stock. As of the latest transaction made, Advisor Net Financial, Inc holds 11,003 shares of EXAS stock, worth $653,578. This represents 0.06% of its overall portfolio holdings.

Number of Shares
11,003
Previous 10,973 0.27%
Holding current value
$653,578
Previous $463,000 61.77%
% of portfolio
0.06%
Previous 0.04%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$42.43 - $70.83 $1,272 - $2,124
30 Added 0.27%
11,003 $749,000
Q2 2024

Jul 16, 2024

BUY
$41.33 - $74.26 $27,732 - $49,828
671 Added 6.51%
10,973 $463,000
Q1 2024

Apr 12, 2024

BUY
$56.27 - $73.77 $82,210 - $107,777
1,461 Added 16.53%
10,302 $711,000
Q4 2023

Jan 19, 2024

BUY
$59.06 - $75.72 $74,238 - $95,180
1,257 Added 16.57%
8,841 $654,000
Q3 2023

Oct 12, 2023

SELL
$65.94 - $99.04 $461 - $693
-7 Reduced 0.09%
7,584 $517,000
Q2 2023

Jul 14, 2023

BUY
$62.68 - $95.05 $71,141 - $107,881
1,135 Added 17.58%
7,591 $712,000
Q1 2023

Apr 28, 2023

BUY
$47.19 - $70.77 $188 - $283
4 Added 0.06%
6,456 $437,000
Q4 2022

Jan 13, 2023

BUY
$30.35 - $53.15 $53,082 - $92,959
1,749 Added 37.19%
6,452 $0
Q3 2022

Oct 04, 2022

BUY
$31.97 - $49.37 $67,456 - $104,170
2,110 Added 81.37%
4,703 $153,000
Q2 2022

Jul 07, 2022

SELL
$35.61 - $76.23 $426,180 - $912,320
-11,968 Reduced 82.19%
2,593 $102,000
Q1 2022

Apr 14, 2022

BUY
$57.56 - $82.54 $155,872 - $223,518
2,708 Added 22.85%
14,561 $1.02 Million
Q4 2021

Jan 19, 2022

BUY
$72.5 - $100.68 $201,332 - $279,588
2,777 Added 30.6%
11,853 $923,000
Q3 2021

Oct 15, 2021

BUY
$90.24 - $124.05 $147,993 - $203,442
1,640 Added 22.05%
9,076 $866,000
Q2 2021

Jul 06, 2021

BUY
$93.66 - $139.27 $46,361 - $68,938
495 Added 7.13%
7,436 $924,000
Q1 2021

Apr 14, 2021

SELL
$116.57 - $155.01 $78,801 - $104,786
-676 Reduced 8.87%
6,941 $915,000
Q4 2020

Feb 04, 2021

SELL
$99.61 - $142.12 $66,639 - $95,078
-669 Reduced 8.07%
7,617 $1.01 Million
Q3 2020

Nov 06, 2020

SELL
$72.92 - $102.01 $151,965 - $212,588
-2,084 Reduced 20.1%
8,286 $845,000
Q2 2020

Aug 26, 2020

SELL
$55.75 - $92.75 $300,994 - $500,757
-5,399 Reduced 34.24%
10,370 $902,000
Q1 2020

May 14, 2020

BUY
$37.9 - $104.44 $103,429 - $285,016
2,729 Added 20.93%
15,769 $915,000
Q4 2019

Feb 12, 2020

BUY
$77.66 - $99.74 $139,166 - $178,734
1,792 Added 15.93%
13,040 $1.21 Million
Q3 2019

Oct 23, 2019

SELL
$90.37 - $122.49 $231,708 - $314,064
-2,564 Reduced 18.56%
11,248 $1.02 Million
Q2 2019

Jul 15, 2019

SELL
$89.51 - $118.04 $401,899 - $529,999
-4,490 Reduced 24.53%
13,812 $1.63 Million
Q1 2019

May 14, 2019

SELL
$61.98 - $96.5 $444,706 - $692,387
-7,175 Reduced 28.16%
18,302 $1.59 Million
Q4 2018

Feb 08, 2019

SELL
$56.04 - $82.66 $66,407 - $97,952
-1,185 Reduced 4.44%
25,477 $1.61 Million
Q3 2018

Nov 14, 2018

SELL
$48.29 - $80.6 $140,668 - $234,787
-2,913 Reduced 9.85%
26,662 $2.1 Million
Q2 2018

Jul 27, 2018

SELL
$37.84 - $69.96 $37,272 - $68,910
-985 Reduced 3.22%
29,575 $1.77 Million
Q1 2018

May 08, 2018

BUY
$39.82 - $57.53 $36,634 - $52,927
920 Added 3.1%
30,560 $1.23 Million
Q4 2017

Feb 27, 2018

BUY
$46.49 - $60.51 $1.38 Million - $1.79 Million
29,640
29,640 $1.56 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.5B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Advisor Net Financial, Inc Portfolio

Follow Advisor Net Financial, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Net Financial, Inc with notifications on news.